HCAT shares surged 7% today. Here's why:

Health Catalyst Inc (HCAT) is trading 7% higher at $12.6 today. While the Health Care sector is having a slightly gloomy day in general, the company is quickly outshining it's peers.

The stock is bursting through a broad market selloff. Here are a few recent pieces of news that could help support the bullish case:

- Director bought 8,400 shares of stock.
- Short Interest Decreased 7.4% in July.
- (HCAT) delivered earnings and revenue surprises of 72.73% and 1.23%, respectively, for the quarter ended June 2022.
- Health Catalyst launches $40M stock buyback plan.

Health Catalyst Inc has been trading between a 52-week high of $57.19 and a 52-week low of $10.95. The stock has a market cap of $690 Million.

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform-powered by data from more than 100 million patient records and encompassing trillions of facts-as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.